Get the Stockscreener App
3.03
6.77%
-0.22
Pre-market:
3.06
0.03
+0.99%
Rocket Pharmaceuticals Inc stock is traded at $3.03, with a volume of 2.62M.
It is down -6.77% in the last 24 hours and down -0.66% over the past month.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.
See More
Previous Close:
$3.25
Open:
$3.24
24h Volume:
2.62M
Relative Volume:
0.66
Market Cap:
$326.95M
Revenue:
-
Net Income/Loss:
$-258.08M
P/E Ratio:
-1.1018
EPS:
-2.75
Net Cash Flow:
$-202.32M
1W Performance:
-4.72%
1M Performance:
-0.66%
6M Performance:
-65.69%
1Y Performance:
-86.10%
1-Day Range:
$3.03
$3.255
1-Week Range:
$3.03
$3.30
52-Week Range:
$2.19
$22.00
Rocket Pharmaceuticals Inc Stock (RCKT) Company Profile
Name
Rocket Pharmaceuticals Inc
Sector
Industry
Phone
646-440-9100
Address
350 FIFTH AVENUE, NEW YORK, NY
Compare RCKT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RCKT
Rocket Pharmaceuticals Inc
|
3.03 | 350.69M | 0 | -258.08M | -202.32M | -2.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.15 | 100.34B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
585.50 | 60.95B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.73 | 60.46B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
734.35 | 46.04B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
332.20 | 36.02B | 3.81B | -644.79M | -669.77M | -6.24 |
Rocket Pharmaceuticals Inc Stock (RCKT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-20-25 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-25-25 | Downgrade | BofA Securities | Buy → Neutral |
| May-30-25 | Downgrade | Evercore ISI | Outperform → In-line |
| May-28-25 | Downgrade | Goldman | Neutral → Sell |
| May-28-25 | Downgrade | JP Morgan | Overweight → Neutral |
| May-28-25 | Downgrade | Jefferies | Buy → Hold |
| May-28-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| May-28-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| May-27-25 | Downgrade | Needham | Buy → Hold |
| May-27-25 | Downgrade | TD Cowen | Buy → Hold |
| Mar-12-25 | Initiated | BMO Capital Markets | Outperform |
| Dec-30-24 | Initiated | Wedbush | Outperform |
| Dec-18-24 | Initiated | Jefferies | Buy |
| Oct-16-24 | Initiated | Scotiabank | Sector Outperform |
| Apr-02-24 | Initiated | Goldman | Neutral |
| Oct-24-23 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-01-23 | Initiated | Morgan Stanley | Overweight |
| Nov-08-22 | Initiated | Canaccord Genuity | Buy |
| Nov-01-22 | Initiated | BTIG Research | Buy |
| Jul-08-22 | Initiated | Raymond James | Outperform |
| Oct-20-21 | Resumed | Cowen | Outperform |
| Mar-02-21 | Initiated | Stifel | Buy |
| Feb-18-21 | Initiated | Needham | Buy |
| Dec-16-20 | Initiated | UBS | Buy |
| Dec-08-20 | Downgrade | Oppenheimer | Outperform → Perform |
| Jul-02-20 | Initiated | JP Morgan | Overweight |
| Jun-25-20 | Resumed | BofA/Merrill | Buy |
| Jun-01-20 | Resumed | Oppenheimer | Outperform |
| Nov-06-19 | Initiated | Chardan Capital Markets | Buy |
| Sep-26-19 | Initiated | Piper Jaffray | Overweight |
| Apr-23-19 | Initiated | Robert W. Baird | Outperform |
| Mar-15-19 | Initiated | BofA/Merrill | Buy |
| Feb-05-19 | Initiated | Oppenheimer | Outperform |
| Sep-13-18 | Initiated | Ladenburg Thalmann | Buy |
| Jul-10-18 | Initiated | William Blair | Outperform |
View All
Rocket Pharmaceuticals Inc Stock (RCKT) Latest News
Rocket Pharmaceuticals enters separation and consulting agreements with Dr. Kinnari Patel - Investing.com
Rocket Pharmaceuticals Announces Dr. Patel’s Departure Agreement - TipRanks
Aug EndMonth: Is Sitio Royalties Corp. in a consolidation phase2025 Trade Ideas & Smart Allocation Stock Tips - خودرو بانک
Market Fear: Is Rocket Pharmaceuticals Inc Equity Warrant forming a breakout patternEntry Point & Low Risk Investment Opportunities - خودرو بانک
Portfolio Shifts: Is Rocket Pharmaceuticals Inc. stock a good pick for beginnersMarket Growth Review & Daily Stock Trend Watchlist - خودرو بانک
Big Money Moves: Is Rocket Pharmaceuticals Inc trading at a discountWeekly Gains Summary & Verified Momentum Watchlists - خودرو بانک
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Rocket Pharmaceuticals, Inc. and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Goldman Sachs Group Inc. Boosts Stock Holdings in Rocket Pharmaceuticals, Inc. $RCKT - MarketBeat
US Stocks Recap: Will Rocket Pharmaceuticals Inc Equity Warrant benefit from AI trendsWeekly Gains Report & Stepwise Trade Execution Plans - خودرو بانک
Dip Buying: Is Ucommune International Ltd Equity Warrant a good stock for dollar cost averagingRate Hike & Momentum Based Trading Ideas - خودرو بانک
Surprises Report: Can Rocket Pharmaceuticals Inc Equity Warrant sustain earnings growth2025 Sector Review & Weekly High Return Opportunities - خودرو بانک
Aug Breakouts: Does Rocket Pharmaceuticals Inc have strong fundamentalsJuly 2025 Closing Moves & Safe Entry Momentum Tips - خودرو بانک
Aug Breakouts: What is Rocket Pharmaceuticals Incs 5 year growth outlookGDP Growth & Long-Term Safe Investment Ideas - خودرو بانک
Market Moves: Should I average down on Rocket Pharmaceuticals Inc. stockTrade Ideas & Daily Growth Stock Tips - خودرو بانک
Risk Check: Is Abrdn Life Sciences Investors stock heavily shortedWeekly Trading Summary & Accurate Intraday Trade Tips - خودرو بانک
Portfolio Recap: Whats the beta of Rocket Pharmaceuticals Inc Equity Warrant stockPortfolio Value Summary & Technical Buy Zone Confirmations - خودرو بانک
Update Recap: Is Rocket Pharmaceuticals Inc Equity Warrant stock good for income investors - خودرو بانک
Rocket Pharmaceuticals, Inc. (RCKT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Rocket Pharmaceuticals, Inc. (RCKT) And Encourages Investors to Connect - ACCESS Newswire
BofA Upgrades Rocket Pharmaceuticals to Buy From Neutral, Adjusts Price Target to $24 From $21 - MarketScreener
Brokerages Set Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) PT at $16.73 - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages Rocket Pharmaceuticals, Inc. (RCKT) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Should I trade or invest in Rocket Pharmaceuticals Inc. Equity Warrant2025 Growth vs Value & Community Trade Idea Sharing - Lancaster City Council
Investigation announced for Long-Term Investors in Rocket - openPR.com
Rocket Pharmaceuticals Inc. Breaks Losing Streak — Is the Trend ReversingPrice Action & Daily Price Action Insights - beatles.ru
Analysts Apply Wyckoff Model to Rocket Pharmaceuticals Inc. Equity Warrant StockQuarterly Risk Review & Real-Time Chart Breakout Alerts - beatles.ru
Russell Investments Group Ltd. Trims Stock Position in Rocket Pharmaceuticals, Inc. $RCKT - MarketBeat
Baker BROS. Advisors LP Acquires 1,000,000 Shares of Rocket Pharmaceuticals, Inc. $RCKT - MarketBeat
Rocket Pharmaceuticals, Inc. $RCKT Shares Bought by MPM Bioimpact LLC - MarketBeat
Is Rocket Pharmaceuticals Inc. Equity Warrant reversing from oversold territoryJuly 2025 Retail & Fast Entry High Yield Tips - Newser
Can machine learning forecast Rocket Pharmaceuticals Inc. recoveryTrade Risk Report & AI Based Buy and Sell Signals - Newser
Nantahala Capital Management LLC Invests $4.20 Million in Rocket Pharmaceuticals, Inc. $RCKT - MarketBeat
Is Rocket Pharmaceuticals Inc. Equity Warrant a candidate for recovery playJuly 2025 Highlights & Consistent Growth Stock Picks - Newser
Market Review: Is Rocket Pharmaceuticals Inc. Equity Warrant currently under institutional pressure - خودرو بانک
How volatile is Rocket Pharmaceuticals Inc. Equity Warrant stockJuly 2025 Gainers & Weekly Consistent Profit Watchlists - خودرو بانک
Nuveen LLC Invests $1.19 Million in Rocket Pharmaceuticals, Inc. $RCKT - MarketBeat
Forecasting Rocket Pharmaceuticals Inc. Equity Warrant price range with options dataTrade Risk Report & Smart Swing Trading Techniques - Newser
Will Rocket Pharmaceuticals Inc. Equity Warrant be affected by tariffsWeekly Profit Summary & Stock Portfolio Risk Control - خودرو بانک
Is Rocket Pharmaceuticals Inc. Equity Warrant forming a double bottomInsider Selling & Weekly Setup with ROI Potential - خودرو بانک
Intraday pattern recognizer results for Rocket Pharmaceuticals Inc.2025 AllTime Highs & Advanced Swing Trade Entry Alerts - Newser
Can Rocket Pharmaceuticals Inc. maintain sales growth2025 Breakouts & Breakdowns & Risk Adjusted Buy/Sell Alerts - خودرو بانک
Smart tools for monitoring Rocket Pharmaceuticals Inc.’s price actionEarnings Miss & Real-Time Volume Trigger Notifications - Newser
Is a relief rally coming for Rocket Pharmaceuticals Inc. Equity Warrant holders2025 Risk Factors & Expert Approved Trade Ideas - Newser
Can trapped investors hope for a rebound in Rocket Pharmaceuticals Inc.2025 Technical Patterns & Long-Term Growth Portfolio Plans - Newser
Advanced analytics toolkit walkthrough for Rocket Pharmaceuticals Inc.Weekly Investment Report & Verified Stock Trade Ideas - Newser
How to read the order book for Rocket Pharmaceuticals Inc.Gold Moves & Long-Term Growth Portfolio Plans - Newser
Can a trend reversal in Rocket Pharmaceuticals Inc. lead to recoveryJuly 2025 Short Interest & Risk Controlled Swing Alerts - Newser
Pattern recognition hints at Rocket Pharmaceuticals Inc. upsideJuly 2025 Recap & High Conviction Buy Zone Picks - Newser
When is the best time to exit Rocket Pharmaceuticals Inc.July 2025 Update & Fast Gain Stock Trading Tips - Newser
Custom watchlist performance reports with Rocket Pharmaceuticals Inc. Equity WarrantEarnings Summary Report & Weekly Top Gainers Alerts - Newser
Leading vs lagging indicators on Rocket Pharmaceuticals Inc. Equity Warrant performanceQuarterly Trade Report & Breakout Confirmation Alerts - Newser
Rocket Pharmaceuticals Inc Stock (RCKT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.62%
0.57%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):